Skip to main content
. 2020 Nov 11;18(1):202–216. doi: 10.1007/s13311-020-00959-7

Table 1.

Key considerations in addressing clinical sleep pathology common in neurodegenerative conditions

Pathology Example of associated neurodegenerative condition Key treatment strategies
Obstructive sleep apnea (OSA)

1. Alzheimer’s disease

2. Vascular dementia

1. Continuous positive airway pressure (CPAP)

2. Mandibular devices

3. Positioning techniques

Restless leg syndrome (RLS) 1. Parkinson’s disease

1. Exclude iron/B12 deficiency

2. Consider contribution of antihistamines/antidepressants/ antipsychotics

3. Dopamine agonists, gabapentin, pregabalin

4. Opiates

Periodic limb movement disorder (PLMD) 1. Huntington’s disease [51]

1. Consider contribution of antidepressants/antipsychotics

2. Dopamine agonists

REM behavior sleep disorder (RBD)

1. Parkinson’s disease

2. Lewy body dementia

3. Multiple system atrophy

1. Consider contribution of antidepressants, beta blockers, opioids, clonidine

2. Melatonin [5759]

3. Clonazepam (except in presence of cognitive impairment/OSA)